gout medicamentation

08.02.2023 • News

Amgen-Horizon Deal under Intense Scrutiny

Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of Alexion in 2021, if it goes ahead. As such, it is under intense scrutiny.

05.01.2016 • News

US Approves AstraZeneca’s Zurampic Gout Drug

23.04.2012 • News

Astra Fuels Biotech M&A with $1.3 bln Ardea Buy

Top-Feature

Evonik Operations GmbH (Hanau)

Biobased Feedstocks as a Roadmap to Defossilization

CHEManager International c/o Wiley-VCH GmbH

Digitalization in the Chemical Industry

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.